Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi; 3
|
|
- Allan Bradford
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Neurol Med Chir (Tokyo) 53, , 2013 Use of High-Field Intraoperative Magnetic Resonance Imaging During Endoscopic Transsphenoidal Surgery for Functioning Pituitary Microadenomas and Small Adenomas Located in the Intrasellar Region Takafumi TANEI, 1 Tetsuya NAGATANI, 2 Norimoto NAKAHARA, 1 Tadashi WATANABE, 3 Tomoki NISHIHATA, 4 Matthew L. NIELSEN, 5 Shigenori TAKEBAYASHI, 1 Masaki HIRANO, 1 and Toshihiko WAKABAYASHI 2 Departments of 1 Neurosurgery and 4 Radiology, Nagoya Central Hospital, Nagoya, Aichi; 2 Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi; 3 Department of Neurosurgery, Nagoya Daini Red Cross Hospital, Nagoya, Aichi; 5 Imaging & Therapy Systems Division, Siemens Japan K.K., Tokyo Abstract The usefulness of 1.5-T high-field intraoperative magnetic resonance (imr) imaging during transsphenoidal surgery for functioning pituitary adenomas was retrospectively evaluated based on longterm endocrine remission from the records of 14 patients who underwent transsphenoidal surgery with imr imaging for functioning pituitary microadenomas and small adenomas located in the intrasellar region. The maximum tumor diameter was 9.3 ± 2.6 mm. Patients were diagnosed with acromegaly (n = 7), prolactinoma (n = 4), and Cushing's disease (n = 3). If imr imaging detected tumor remnants after resection, the resection cavity was reexamined and further resection was performed. Postoperative endocrine follow-up period was mean 33.7 ± 13.3 months. Tumor remnants were detected after the first resection in seven patients. Further resection was performed in five of these patients, and three achieved long-term endocrine remission. As a result, the overall long-term endocrine remission rate was 78.5% (11/14), instead of the 57.1% (8/14) that would be expected if imr imaging had not been performed. Long-term endocrine remission had a tendency to be associated with the absence of tumor remnants on the final imr images, but this was not significant (p = 0.09). Long-term endocrine remission was associated with presence of tumor remnants in the cavernous sinus on the final imr images (p = 0.03). High-field imr imaging is useful for depicting tumor remnants after resection, and increased the long-term endocrine remission rate for patients with functioning pituitary microadenomas and small adenomas. Key words: functioning pituitary adenoma, high-field intraoperative magnetic resonance imaging, intrasellar region Introduction In recent years, advanced technologies such as neuronavigation and endoscopy have been used as adjuvant techniques in transsphenoidal surgery. 1,7,16,18) The endoscopic approach improves visualization and overcomes certain drawbacks of microsurgical approaches. However, even when applying endoscopic techniques, a small part of pituitary adenomas can be overlooked. Intraoperative magnetic Received October 16, 2012; Accepted December 17, 2012 resonance (imr) imaging combined with a neuronavigation system can provide real-time navigation images and enable image-guided surgery, allowing the surgeon to correct morphological and structural deformations that occur during tumor resection. In addition, visualizing tumor remnants using imr imaging allows an objective judgment of whether to perform further tumor resection. As a result, the use of imr imaging increases the rate of complete tumor removal and thus prevents further unnecessary exploration. 2,10,11,24,29 31,33) High-field (1.5 tesla) imr imaging offers superior image quality to low-field ( tesla) imr imaging, and can de- 501
2 502 T. Tanei et al. tect intra- or para-sellar tumor remnants in addition to suprasellar tumor remnants. 10,24,30) This may be advantageous in the treatment of patients with functioning microadenomas or small pituitary adenomas located in the intrasellar region. Although functioning microadenomas or small adenomas have high endocrine remission rates after transsphenoidal surgery, not all patients achieve endocrine remission. 6,9,13,22) Our first hypothesis is that further resections of intrasellar remnant tumors depicted by high-field imr imaging will increase long-term endocrine remission rate. There is only one previous report of high-field imr imaging in transsphenoidal surgery for functioning pituitary adenomas. 10) Therefore, the reliability of high-field imr imaging, especially of the intra- and para-sellar regions, is still unclear. Tumor remnants prevent endocrine remission or cause recurrence, and remission status after surgery can therefore be used as an indicator of the reliability of imr imaging. 35) Our second hypothesis is that longterm endocrine status will be associated with the presence or absence of tumor remnants on imr imaging at the end of transsphenoidal surgery. Tumor invasion of the cavernous sinus (CS) is correlated with poor endocrine outcome after surgery. 6,9,13,22,30) However, postoperative changes make it difficult to interpret postoperative MR imaging in the intrasellar and CS region, 35) and it is therefore difficult to judge whether or not remnant tumors are present. Our third hypothesis is that long-term endocrine status will be associated with the presence or absence of tumor remnants in the CS on the imr imaging at the end of transsphenoidal surgery. The present study was intended to evaluate our three hypotheses. Patients and Methods I. Patient population A total of 67 patients with pituitary adenomas underwent endoscopic transsphenoidal surgery using high-field imr imaging at the Department of Neurosurgery of Nagoya Central Hospital between September 2006 and June Thirty-nine of these patients had nonfunctioning pituitary adenomas and 28 had functioning pituitary adenomas. We reviewed the records of all 28 patients with functioning pituitary adenomas. Microadenoma was defined as a pituitary tumor with a maximum diameter º1 cm, or a small adenoma, defined as a pituitary tumor located only in the intrasellar region. Of the 28 patients with functioning pituitary adenomas, 14 (2 men and 12 women; age, mean ± standard deviation [SD] 37.4 ± 11.8 years) were classified with microadenomas (n = 7) or small adenomas (n = 7) and were included in the present analysis. The maximum tumor diameter was 9.3 ± 2.6 mm (mean ± SD). All patients presented with clinical symptoms due to hormone hypersecretion and had pituitary tumor on MR imaging. Preoperative diagnosis was made by endocrinologists, and was acromegaly in 7 patients, prolactinoma in 4, and Cushing's disease in 3. Preoperative MR imaging revealed that two patients had tiny tumor invasion of the CS, nine patients had tumor attached to the CS without invasion, and three patients had no attachment of tumor to the CS. Patient details are summarized in Table 1. II. Endocrine assessments Postoperative endocrine assessments were performed on the first postoperative day and every 3 months thereafter. All follow-up examinations were performed at on-site visits. We analyzed the assessments that were obtained on the first postoperative day, 3 months postoperatively, and the latest followup time point. The endocrine follow-up period was months (mean ± SD 33.7 ± 13.3 months). Endocrine remission was determined at 3 months postoperatively, and was defined as improvement of preoperative clinical symptoms and normalization of endocrine levels. Endocrine remission of acromegaly was defined as basal plasma growth hormone º1.0 ng/ml and normalization of age-related insulin-like growth factor-1. Endocrine remission of prolactinoma was defined as basal plasma prolactin (PRL) º20 ng/ml. Endocrine remission of Cushing's disease was defined as normalization of basal plasma adrenocorticotropic hormone and either dependency on glucocorticoid substitutions or morning plasma cortisol between 6 and 26 mg/dl without hormone replacement. 15) Patients who did not meet these criteria at 3 months postoperatively were considered to have persistent active disease. Patients who did meet these criteria at 3 months postoperatively were considered to be in remission. Patients who maintained this status until the latest follow-up time point were considered to be in long-term remission. Endocrine recurrence was defined as remission at 3 months postoperatively but reappearance of clinical symptoms and secondary increase in plasma hormone levels above the normal range during follow-up. III. Operating room setup The high-field strength (1.5 tesla) MR imager (Magnetom Symphony; Siemens Healthcare, Erlangen, Germany) consisted of a superconductive magnet (length 160 cm, inner bore diameter 60 cm, gradient system maximum field strength 30 mt/m,
3 High-Field imr Imaging for Functioning Pituitary Adenomas 503 Table 1 Patient characteristics, intraoperative magnetic resonance (imr) imaging findings, and endocrine outcomes Case No. Age (yrs) Sex Function Follow up (mos) Size (mm) Tumor characteristics Invasion of the CS Attachment to the CS Tumor remnants on 1st imr imaging Further resection performed Tumor remnants on final imr imaging Endocrine outcomes Plasma hormone levels* Remission at 3 mos Long-term 1Day remission Hormone Preop. postop. 3Mos postop. Final follow-up 1 29 F PRLoma no yes yes yes no yes no PRL a 2 29 M Acro no yes yes yes no yes yes GH IGF F Acro no yes yes yes no yes yes GH IGF F PRLoma no no no no no yes yes PRL F Cushing yes yes yes yes no no ACTH a 93 a cortisol b 18.5 b 6 56 F Cushing no no no no no yes yes ACTH cortisol c 8.1 c 7 43 F Acro no yes yes yes no yes yes GH IGF F Acro no yes no no no yes yes GH IGF F Acro no no no no no yes yes GH IGF F Cushing no yes no no no yes yes ACTH cortisol c 2.7 c F Acro no yes no no no yes yes GH IGF F PRLoma no yes no no no yes yes PRL F PRLoma no yes yes no yes yes yes PRL M Acro yes yes no yes no no GH a 0.3 d IGF a 379 d a Plasma hormone levels above the upper normal limit. b Morning plasma cortisol level without hormone replacement. c Morning plasma cortisol level with hormone replacement. d Plasma growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels with octreotide acetate. *Units are ng/ml for prolactin (PRL), GH, and IGF-1, or mg/dl for adrenocorticotropic hormone (ACTH) and cortisol. Acro: acromegaly, CS: cavernous sinus, Cushing: Cushing disease, F: female, M: male, preop.: preoperative, postop.: postoperative, PRLoma: prolactinoma.
4 504 T. Tanei et al. and effective slew rate 125 T/m/sec) and was located in an operating room with radiofrequency shielding. The operating table was positioned parallel to the scanner during surgery so that the patient's head was outside the 5-gauss line. When imaging was necessary, the table was manually rotated by 180 degrees about a vertical axis to align it with the scanner bore. The head-holder had a bivalve shape, consisting of two parts, and contained an 8-channel receiver array. The upper part of the head-holder was sterilized with plasma and placed above the operating field for MR imaging, but was removed during surgery. Rapid automatic image registration was realized with a reference array attached to the upper part of the head-holder. The array contained 14 MR imaging-visible fiducial markers and four infrared reflector spheres that were continuously tracked by a ceiling-mounted infrared camera. Navigation was accomplished with an error º0.6 mm. IV. Preoperative MR imaging Before surgery, the patient's head was fixed in the head holder with five metallic pins, and MR imaging with three sequences was performed. Fat suppression MR images were taken using fat saturation pulses, and the pulse sequence was called ``FatSat'' (FS). A pulse sequence with a reduced frequency of fat saturation pulses was called ``Quick FatSat'' (Q- FS). First, T 2 -weightedimageswereacquiredinthe sagittal and coronal planes using two-dimensional turbo spin echo with the FS pulse sequence. Images were acquired in stacks of 17 slices that were centered on the pituitary gland and covered 30 mm along the slice axis (1.6 mm slice thickness). Next, contrast-enhanced T 1 -weighted images were acquired in the coronal plane using the Q-FS pulse sequence with three-dimensional (3D) fast low angle shot (FLASH) in a 107-mm-thick slab centered on the pituitary gland (0.7 mm slice thickness). This T 1 - weighted Q-FS 3D FLASH sequence is called volumetric interpolated brain examination (VIBE). 17,32) Finally, T 1 -weighted 3D FLASH images of the entire head and fiducial markers were acquired to be used as reference images for registration with the navigation system. The contrast-enhanced VIBE and T 1 - weighted 3D FLASH images were sent to the navigation system. V. imr imaging Transsphenoidal surgery was performed by endonasal endoscopy using rigid endoscopes that visualized the surgical site on a monitor without a microscope. The whole transsphenoidal procedure was same as the regular operating technique. The adenoma was removed using curettes, grasping forceps, and suction devices. The first imr imaging was performed when the surgeon judged that most or all of the tumor had been excised. Bone wax was placed inside the resection cavity to prevent the blood from pooling and to improve interpretation of theintraoperativeimages.thesurgicalsitewascovered with a sterile drape and the surgical table rotated 180 degrees into the center of the scanner. imr images were obtained using two types of pulse sequences, T 2 -weighted turbo spin echo and contrast-enhanced VIBE, in the same manner as the preoperative MR imaging. If this first imr imaging depicted tumor remnants, new contrast-enhanced VIBE images were sent to the navigation system, the resection cavity was reexamined, and further resection was performed. In the case of intraoperative cerebrospinal fluid leakage, the intrasellar region was packed with abdominal fat that was obtained from the right lower abdomen and covered with fibrin glue. Final imr imaging was performed after all surgical procedures were completed. The final imr image was used to determine the presence or absence of tumor remnants, and the presence or absence of tumor remnants in the CS. VI. Statistical analysis The associations between the final imr imaging finding (tumor remnants or no tumor remnants) and endocrine outcome (remission or no remission), and between the final imr imaging finding (tumor remnants in the CS or no tumor remnants in the CS) and endocrine outcome (remission or no remission), were analyzed by Fisher's exact test using JMP} software (SAS Institute Inc., Cary, North Carolina, USA). Probability values º0.05 were considered statistically significant. Results Long-term endocrine remission was achieved by 11 ofthe14patients.figure1givesanoverviewofthe results and consequences of imr imaging in all 14 cases. The first imr image after resection showed no tumor remnants in 7 patients. No further resection was performed, and all seven patients achieved long-term endocrine remission (Fig. 1). In the other seven patients, the first imr image after resection indicated some tumor remnants. Further resection was performed in five patients, and remnant tumor tissues were found. Further resection was not performed in the other two patients because the remnant tumor had invaded the CS (Case 14; Fig. 2) or had strongly adhered to the normal pituitary gland (Case13).Threeofthefivepatientswhoreceived further resection went on to achieve long-term endo-
5 High-Field imr Imaging for Functioning Pituitary Adenomas 505 Fig. 1 Overview of the results and consequences of high-field intraoperative magnetic resonance (imr) imaging used in transsphenoidal surgery for functioning pituitary microadenomas and small adenomas located in the intrasellar region of 14 patients. After each resection, imr images were examined for tumor remnants. If evidence of tumor remnants was present, further resection was considered. Patients were classified as ``Remission'' or ``No remission'' according to their endocrine status at final follow-up. False negative indicates no remnant tumor identified on the final imr image but patient did not achieve endocrine remission. False positive indicates remnant tumor identified on the final imr image but patient achieved endocrine remission. crine remission. One of these cases is illustrated in Fig. 3. Tiny tumor remnants were depicted on contrast-enhanced VIBE images, and the presence of remnant tumor tissue was confirmed by endoscopy (Fig. 4). Two of the five patients who received further resection did not go on to achieve endocrine remission. In one patient (Case 5) further partial resection was performed, but the remnant tumor invading the CS portion was not resected. In the other patient (Case 1), complete tumor removal was confirmed by endoscopy and final imr imaging, and the patient was in endocrine remission at 3 months postoperatively. However, plasma PRL level was elevated at 16 months postoperatively, so this case was classified as recurrent. In this case, the final imr imaging finding (no tumor remnants) gave a falsenegativeaccordingtothelong-termendocrine remission status. As a result, the overall long-term endocrine remission rate was 78.6% (11/14), instead of the 57.1% (8/14) that would be expected if imr imaging had not been performed. Further resections of the remnant tumors depicted by the imr imaging therefore led to a 21.4% (3/14) increase in the longterm endocrine remission rate. Eleven patients were classified as having no tumor remnants on the final imr image, and 10 of these achieved long-term endocrine remission. Three patients were classified as having some tumor remnants on the final imr image. In two of these cases, the remnant tumor was located in the CS, and although plasma hormone levels had decreased slightly at the first postoperative day, they subsequently increased and the patients did not achieve endocrine remission. In the other patient (Case 13), the remnant tumor could not be completely removed because the tumor was fibrous and strongly adhered to the normal pituitary gland. However, this patient achieved long-term endocrine remission. In this patient, the final imr imaging finding (tumor remnants) gave a false positive according to the longterm endocrine remission status. Long-term endocrine remission tended to be associated with the absence of tumor remnant findings on the final imr image, but this did not reach the level of statistical significance (Fisher's exact test, p = 0.09). The patients with false negative and false positive find-
6 506 T. Tanei et al. Fig. 2 Magnetic resonance (MR) images of a 42-yearold male who presented with hypersecretion of growth hormone (Case 14). A, B: Preoperative coronal MR images showing a small pituitary adenoma located in the intrasellar region with invasion of the cavernous sinus. The adenoma is evident as an area of low intensity on the contrast-enhanced volumetric interpolated brain examination image (A), and as an area of isointensity on the T 2 -weighted image (B). C, D: Intraoperative coronal MR images obtained after the first resection showing a tiny tumor remnant at the cavernous sinus on the contrast-enhanced volumetric interpolated brain examination image (C, arrow), that is not evident on the T 2 - weighted MR image (D). Fig. 3 Magnetic resonance (MR) images of a 41-yearold female who presented with hypersecretion of growth hormone (Case 3). A, B: Preoperative coronal MR images showing a small pituitary adenoma located in the intrasellar region and attached to the cavernous sinus. The adenoma is evident as an area of low intensity on the contrast-enhanced volumetric interpolated brain examination image (A), and an area of low intensity on the T 2 -weighted image (B). C, D: Intraoperative coronal MR images obtained after resection showing a tiny tumor remnant at the superior lateral side of the tumor removal cavity on the contrast-enhanced volumetric interpolated brain examination image (C, arrow), that is not evident on the T 2 -weighted MR image (D). Fig. 4 Case 3. Intraoperative endoscopic view showing tiny remnant tumor tissues (arrow), consistent with the intraoperative magnetic resonance imaging findings. ings both had prolactinoma, both were taking cabergoline preoperatively, and the tumors consisted mainly of fibrous components on endoscopic examination. Twelve patients were classified as having no tumor remnants in the CS on the final imr image. Of these 12 patients, 11 achieved long-term endocrine remission. Neither of the two cases that were classified as having tumor remnants in the CS on the final imr image achieved long-term endocrine remission. The final imr imaging finding of tumor remnants in the CS was associated with a failure to achieve longterm endocrine remission (Fisher's exact test, p = 0.03). There were no adverse events related to high-field imr imaging, and no accidents caused by the ferromagnetic instruments. Postoperative endocrine evaluations did not reveal new endocrine deterioration of pituitary hormones. Intraoperative cerebrospinal fluid leakages were identified in eight patients. Postoperative cerebrospinal fluid leakage was not identified in any patients. Postoperatively, nine patients had diabetes insipidus and two patients had syndrome of inappropriate secretion of antidiuretic hormone. All of these complications were transient and improved within 2 weeks of surgery. There were no permanent complications or deaths during the follow-up period. Discussion The results of this retrospective review support our three hypotheses. Further resection of remnant tumors depicted by imr imaging increased the long-
7 High-Field imr Imaging for Functioning Pituitary Adenomas 507 term endocrine remission rate from 57.1% to 78.6%, and long-term endocrine remission tended to be associated with absence of tumor remnants on the final imr images, and was associated with tumor remnants in the CS on the final imr images. Even tiny remnant tumors were associated with a failure to achieve long-term endocrine remission. imr imaging and its neurosurgical applications were first described in ) Since this time, imr imaging has been frequently applied, particularly in craniotomies. 3,12) The first uses of imr imaging in transsphenoidal surgery for pituitary adenomas were reported around 2000, 5,20,25) and imr imaging is now well known to be an effective and safe modality for transsphenoidal surgery of pituitary adenomas. 2,11,24,29,31,33) Detection and visualization of tumor remnants by imr imaging contributes to an increased rate of complete tumor removal, and prevents unnecessary exploration and injury around normal tissues. 30) imr imaging can be classified as low ( tesla), medium (0.5 tesla), or high (À1.5 tesla) field according to the strength of the magnetic field used. In transsphenoidal surgery for nonfunctioning macroadenomas, low-field imr imaging revealed residual tumor and resulted in further resection in 17 of 55 cases, and the rate of complete tumor removal increased from 58% to 84%. 33) Similarly, in transsphenoidal surgery for nonfunctioning macroadenomas, high-field imr imaging revealed residual tumor and resulted in further resection in 36 of 85 cases, and the rate of complete tumor removal increased from 58% to 82%. 24) Therefore, imr imaging is effective at increasing the rate of complete removal of nonfunctioning macroadenomas, regardless of the strength of the magnetic field. In contrast, imr imaging has rarely been used in transsphenoidal surgery for functioning pituitary adenomas. 2,10) The main aim of surgical management for functioning microadenomas or small adenomas is endocrine remission. Therefore, evaluation of surgical outcomes must be based on whether endocrine remission is achieved. 35) Evaluation of true endocrine remission requires long-term follow up to avoid the possibility of transient endocrine remission or recurrence. 27,35) In our study, one patient experienced endocrine recurrence at 16 months postoperatively. In transsphenoidal surgery for acromegaly, high-field imr imaging increased the rate of endocrine normalization during the 3 months postoperatively from 33% to 44%. 10) In transsphenoidal surgery for acromegaly, ultra low-field imr imaging increased the remission rate by 5.1% duringthefirstpostoperativemonth. 2) In our study, high-field imr imaging increased the long-term remission rate from 57% to 79% during month postoperative period. We consider the high-field imr imaging findings of tumor remnants in the intrasellar or CS regions to be highly reliable, because all five patients who underwent further resections had the presence of remnant tumor tissues confirmed by endoscopy, and no patient with tumor remnants in the CS achieved long-term endocrine remission. Pseudocapsulectomy was tried to remove the tumor en bloc in many cases of microadenomas, but the procedure was not completed in some cases, resulting in remnant tumor tissues. Remnant tumor tissues were prone to remain at the bottom of the sella turcica, which is a blind angle for endoscopy. The association between long-term endocrine remission status and the absence of tumor remnants on the final imr images did not reach the level of statistical significance; however, we believe that this finding is because of the small number of patients. Morphologically complete tumor resection is a prerequisite for patients with functioning adenomas to achieve long-term endocrine remission. Tumor remnants prevent endocrine remission or induce endocrine recurrence. 6,22,35) Anatomical localization of the tumor is one of important factors for endocrine outcomes. Tumor invasion of the CS is correlated with poor endocrine outcome after surgery. 6,9,13,22,30) Complete tumor removal was not achieved in either of our two patients who had tiny tumor remnants in the CS on the final imr images, and the presence of tumor remnants in the CS was significantly associated with failure to achieve long-term endocrine remission. These findings suggest that high-field imr imaging can reliably detect the presence of tiny tumor remnants in the CS. Interpretation of the intra- and para-sellar regions on postoperative MR images is difficult due to postoperative changes. 35) In determining whether or not remnant tumors are present, high-field imr imaging may have an advantage over postoperative MR imaging because it is not confounded by such postoperative changes. Early confirmation of the presence of remnant tumors allows the implementation of early supplementary treatments such as gamma knife surgery and medical therapy. If the tumor invades the CS, complete tumor removal is difficult to achieve by the standard transsphenoidal approach and long-term endocrine remission is unlikely. Therefore, although high-field imr imaging can depict tiny remnant tumors in the CS, removing these tumors requires other techniques. 8,34) Another technique to increase long-term endocrine remission rate may be intraoperative measurement of plasma hormone level, as if the plasma hormone level did not sufficiently decline, additional searching for tumor resulted in higher rate of complete tumor resection and remission. 19)
8 508 T. Tanei et al. One of the advantages of high-field imr imaging is the higher image quality compared to low-field imr imaging, meaning that tiny tumor remnants can be detected not only in the suprasellar region, but also the intrasellar region and the CS. 10,24,30) Therefore, high-field imr imaging has the advantage of being able to depict tiny tumor remnants in patients with microadenomas or small adenomas located in the intrasellar region. In this study, contrast-enhanced VIBE images were very useful for depicting tiny tumor remnants. VIBE sequence was originally developed for abdominal imaging, 28) but several studies have reported the usefulness for brain imaging. 17,32) By reducing the frequency of fat saturation pulses, the VIBE sequence has a shorter acquisition time than conventional T 1 -weighted pulse sequences with FS. Therefore, high-resolution T 1 -weighted Q-FS images can be acquired by obtaining thin slices without lengthening acquisition time. High (sub-millimeter) resolution MR images can detect tiny tumor remnants after tumor resection. 24) Tumor remnants are depicted more clearly by using contrast medium; the pituitary adenomas are depicted as less enhanced lesions compared to normal pituitary gland. T 2 -weightedfsimagingcandetectpituitary adenomas preoperatively, but intraoperative image quality is degraded due to artifacts induced by contamination from blood, saline, and air. Of our five patients who underwent further resections, remnant tumors were depicted on contrast-enhanced VIBE images and detected by endoscopy, whereas the remnants were not found on the intraoperative T 2 -weightedfsimages. Weobservedonefalsenegativecase(noremnant tumor identified on imr imaging but did not achieve endocrine remission) and one false positive case (remnant tumor identified on imr imaging but endocrine remission achieved). Both patients had prolactinomas and were taking cabergoline preoperatively, and the tumors were mainly fibrous components. Dopamine agonists such as bromocriptine, cabergoline, and quinagolide are the most effective pharmacological tools to normalize plasma PRL levels with prolactinomas. 23) Although the impact of long-term dopamine agonist therapy on subsequent surgical treatment is controversial, with some reports of similar or better surgical outcomes following surgery after pretreatment with dopamine agonist therapy, 14,26) including one study suggesting that the surgical remission rate is lower following dopamine agonist therapy. 21) Patients exposed to dopamine agonists were more likely to have tumor fibrosis, and fibrous tumors had lower probability of going into endocrine remission than non-fibrous tumors, suggesting that fibrosis may interfere with a complete hormonal cure. 21) Therefore, fibrous tumors may be one of the factors contributing to the false positive or negative findings on imr imaging, and may be a risk factor for long-term endocrine remission. High-field imr imaging is a useful supporting technique for endoscopic transsphenoidal surgery of functioning pituitary microadenomas and small adenomas located in the intrasellar region, and increased the overall long-term endocrine remission rates from 57% to 79%. In addition, visualization of tumor remnants by imr imaging may prevent unnecessary exploration and injury to normal tissues. The present study is limited because of the small number of patients. Further studies of larger cohorts are needed to confirm the usefulness of high-field imr imaging during endoscopic transsphenoidal surgery of functioning pituitary adenomas. Conflicts of Interest Disclosure No financial support was received for this research. The findings presented herein have not been previouslypublished.t.tanei,t.nagatani,n.nakahara, T. Watanabe, S. Takebayashi, M. Hirano, and T. Wakabayashi have registered online Self-reported COI Disclosure Statement Forms through the website for The Japan Neurosurgical Society members. References 1) Anand VK, Schwartz TH, Hiltzik DH, Kacker A: Endoscopic transsphenoidal pituitary surgery with realtime intraoperative magnetic resonance imaging. Am JRhinol20: , ) Bellut D, Hlavica M, Schmid C, Bernays RL: Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly. Neurosurg Focus 29(4): E9, ) BlackPM,AlexanderE3rd,MartinC,MoriartyT, Nabavi A, Wong TZ, Schwartz RB, Jolesz F: Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 45: , ) Black PM, Moriarty T, Alexander E 3rd, Stieg P, Woodard EJ, Gleason PL, Martin CH, Kikinis R, Schwartz RB, Jolesz FA: Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 41: , ) Bohinski RJ, Warnick RE, Gaskill-Shipley MF, Zuccarello M, van Loveren HR, Kormos DW, Tew JM Jr: Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 49: , ) Campbell PG, McGettigan B, Luginbuhl A, Yadla S,
9 High-Field imr Imaging for Functioning Pituitary Adenomas 509 Rosen M, Evans JJ: Endocrinological and ophthalmological consequences of an initial endonasal endoscopic approach for resection of craniopharyngiomas. Neurosurg Focus 28(4): E8, ) Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G, de Divitiis E: Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg 9: , ) Ceylan S, Koc K, Anik I: Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg 112: , ) Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G: Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Neurol Sci 25: , ) Fahlbusch R, Keller B, Ganslandt O, Kreutzer J, Nimsky C: Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging. Eur J Endocrinol 153: , ) Gerlach R, du Mesnil de Rochemont R, Gasser T, MarquardtG,ReuschJ,ImoehlL,SeifertV:Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenomas: lessons learned from the first 40 cases. Neurosurgery 63: , ) Hatiboglu MA, Weinberg JS, Suki D, Rao G, Prabhu SS, Shah K, Jackson E, Sawaya R: Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis. Neurosurgery 64: , ) Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH: Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus 30(4): E10, ) Hubbard JL, Scheithauer BW, Abboud CF, Laws ER Jr: Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome. J Neurosurg 67: , ) Hwang YC, Chung JH, Min YK, Lee MS, Lee MK, Kim KW: Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes. JKorean Med Sci 24: 46 51, ) Jho HD, Alfieri A: Endoscopic transsphenoidal pituitary surgery: various surgical techniques and recommended steps for procedural transition. Br J Neurosurg 14: , ) Kataoka M, Ueda H, Koyama T, Umeoka S, Togashi K, Asato R, Tanaka S, Ito J: Contrast-enhanced volumetric interpolated breath-hold examination comparedwithspin-echot1-weightedimagingofhead and neck tumors. AJR Am J Roentgenol 184: , ) Kuroki A, Kayama T: Endoscopic approach to the pituitary lesions: contemporary method and review of the literature. Biomed Pharmacother 56 Suppl 1: 158s 164s, ) Ludecke DK, Abe T: Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology 83: , ) Martin CH, Schwartz R, Jolesz F, Black PM: Transsphenoidal resection of pituitary adenomas in an intraoperative MRI unit. Pituitary 2: , ) Menucci M, Quinones-Hinojosa A, Burger P, Salvatori R: Effect of dopaminergic drug treatment on surgical findings in prolactinomas. Pituitary 14: 68 74, ) Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburrano G, Cantore G: Evolving criteria for postoperative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocr Relat Cancer 10: , ) Missale C, Nash SR, Robinson SW, Jaber M, Caron MG: Dopamine receptors: from structure to function. Physiol Rev 78: , ) Nimsky C, von Keller B, Ganslandt O, Fahlbusch R: Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 59: , ) Pergolizzi RS Jr, Nabavi A, Schwartz RB, Hsu L, Wong TZ, Martin C, Black PM, Jolesz FA: Intra-operativeMRguidanceduringtrans-sphenoidalpituitary resection: preliminary results. J Magn Reson Imaging 13: , ) Perrin G, Treluyer C, Trouillas J, Sassolas G, Goutelle A: Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas. Pathol Res Pract 187: , ) Roelfsema F, Biermasz NR, Pereira AM: Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15: 71 83, ) RofskyNM,LeeVS,LaubG,PollackMA,Krinsky GA, Thomasson D, Ambrosino MM, Weinreb JC: Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212: , ) Schwartz TH, Stieg PE, Anand VK: Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Neurosurgery 58(1 Suppl): ONS44 ONS51, ) Szerlip NJ, Zhang YC, Placantonakis DG, Goldman M, Colevas KB, Rubin DG, Kobylarz EJ, Karimi S, Girotra M, Tabar V: Transsphenoidal resection of sellar tumors using high-field intraoperative magnetic resonance imaging. Skull Base 21: , ) Vitaz TW, Inkabi KE, Carrubba CJ: Intraoperative MRI for transsphenoidal procedures: short-term outcome for 100 consecutive cases. Clin Neurol Neurosurg 113: , 2011
10 510 T. Tanei et al. 32) Wetzel SG, Johnson G, Tan AG, Cha S, Knopp EA, Lee VS, Thomasson D, Rofsky NM: Three-dimensional, T1-weighted gradient-echo imaging of the brain with a volumetric interpolated examination. AJNR Am J Neuroradiol 23: , ) WuJS,ShouXF,YaoCJ,WangYF,ZhuangDX,Mao Y, Li SQ, Zhou LF: Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging. Neurosurgery 65: 63 71, ) Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang J, Ma WB, Yang Y, Wang RZ: Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J Neurosurg 112: , ) Zirkzee EJ, Corssmit EP, Biermasz NR, Brouwer PA, Wiggers-De Bruine FT, Kroft LJ, Van Buchem MA, Roelfsema F, Pereira AM, Smit JW, Romijn JA: Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery. J Clin Endocrinol Metab 89: , 2004 Address reprint requests to: Takafumi Tanei, MD, PhD, Department of Neurosurgery, Nagoya Central Hospital, Taiko, Nakamura ku, Nagoya , Japan. nsgtakasyun@msn.com
See the corresponding editorial in this issue, pp J Neurosurg 120: , 2014 AANS, 2014
See the corresponding editorial in this issue, pp 342 345. J Neurosurg 120:346 356, 2014 AANS, 2014 Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective
More informationSomatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)
Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland. In patients
More informationLong-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure?
J Neurosurg (Suppl) 102:119 123, 2005 Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure? TATSUYA KOBAYASHI, M.D., PH.D., YOSHIMASA
More informationImaging pituitary gland tumors
November 2005 Imaging pituitary gland tumors Neel Varshney,, Harvard Medical School Year IV Two categories of presenting signs of a pituitary mass Functional tumors present with symptoms due to excess
More informationVisualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use
International Congress Series 1281 (2005) 793 797 www.ics-elsevier.com Visualization strategies for major white matter tracts identified by diffusion tensor imaging for intraoperative use Ch. Nimsky a,b,
More informationMetoclopramide Domperidone. HYPER- PROLACTINAEMIA: the true and the false problems
Modern management of Hyperprolactinaemia Didier DEWAILLY, M.D. Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre, C.H.R.U., 59037 Lille, France 1 Metoclopramide Domperidone
More informationTranssphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging
European Journal of Endocrinology (2005) 153 239 248 ISSN 0804-4643 CLINICAL STUDY Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging Rudolf Fahlbusch,
More informationSurgical therapeutic strategy for giant pituitary adenomas.
Biomedical Research 2017; 28 (19): 8284-8288 ISSN 0970-938X www.biomedres.info Surgical therapeutic strategy for giant pituitary adenomas. Han-Shun Deng, Zhi-Quan Ding, Sheng-fan Zhang, Zhi-Qiang Fa, Qing-Hua
More informationTrans-sphenoidal resection is a well known surgical procedure
Published June 23, 2011 as 10.3174/ajnr.A2506 ORIGINAL RESEARCH C.-C. Lee S.-T. Lee C.-N. Chang P.-C. Pai Y.-L. Chen T.-C. Hsieh C.-C. Chuang Volumetric Measurement for Comparison of the Accuracy between
More informationIntraoperative magnetic resonance imaging-guided transsphenoidal surgery for giant pituitary adenomas
Neurosurg Rev (2010) 33:83 90 DOI 10.1007/s10143-009-0230-4 ORIGINAL ARTICLE Intraoperative magnetic resonance imaging-guided transsphenoidal surgery for giant pituitary adenomas Fabian Baumann & Christoph
More informationPreliminary Experience with 3-Tesla MRI and Cushing s Disease
TECHNICAL NOTE Preliminary Experience with 3-Tesla MRI and Cushing s Disease LouisJ.Kim,M.D., 1 Gregory P. Lekovic, M.D., Ph.D., J.D., 1 William L.White, M.D., 1 and John Karis, M.D. 2 ABSTRACT Because
More informationOctober 13, Surgical Nuances to Managing Cushing s Disease. Cortisol Regulation. Cushing s Syndrome Excess Cortisol. Sandeep Kunwar, M.D.
Surgical Nuances to Managing Cushing s Disease Cortisol Regulation Sandeep Kunwar, M.D. Surgical Director, California Center for Pituitary Disorders Associate Clinical Professor, University of California,
More informationTABLES. Table 1: Imaging. Congress of Neurological Surgeons Author (Year) Description of Study Classification Process / Evidence Class
TABLES Table 1: Imaging Kremer et al (2002) 2 Study Design: Prospective followed case series. Patient Population: Fifty adult patients with NFPA Study Description: Patients underwent MRI before surgery,
More informationBinostril Endoscopic Trans-Sphenoidal Approach for Pituitary Adenomas
Med. J. Cairo Univ., Vol. 85, No. 4, June: 1593-1600, 2017 www.medicaljournalofcairouniversity.net Binostril Endoscopic Trans-Sphenoidal Approach for Pituitary Adenomas HESHAM ABO RAHMA, M.D. and AHMED
More informationNeurosurg Focus 29 (4):
Neurosurg Focus 29 (4):E6, 2010 Endoscopic endonasal transsphenoidal surgery for growth hormone secreting pituitary adenomas Ch r i s t o p h P. Ho f s t e t t e r, M.D., Ph.D., 1 Ra a i d H. Man n a a,
More informationAbstract. Introduction
Clinical Features and Outcome of Surgery in 30 Patients with Acromegaly A. Chandna, N. Islam, A. Jabbar, L. Zuberi, N. Haque Endocrinology Section, Department of Medicine, Aga Khan University Hospital,
More informationProlactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)
Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland.
More informationPituitary Macroadenoma with Superior Orbital Fissure Syndrome
1 CASE REPORT OPEN ACCESS Pituitary Macroadenoma with Superior Orbital Fissure Syndrome Tapan Nagpal, Ankit Singhania ABSTRACT Introduction: Pituitary adenomas are benign tumours which arise within the
More informationRecent developments in transsphenoidal surgery of pituitary tumors
HORMONES 2004, 3(2):85-91 Review Recent developments in transsphenoidal surgery of pituitary tumors Panagiotis Nomikos 1, Rudolf Fahlbusch 2, Michael Buchfelder 1 1 Department of Neurosurgery, University
More informationTherapeutic Objectives. Cushing s Disease Surgical Results. Cushing s Disease Surgical Results: Macroadenomas 10/24/2015
Therapeutic Objectives Update on the Management of Lewis S. Blevins, Jr., M.D. Correct the syndrome by lowering daily cortisol secretion to normal Eradicate any tumor that might threaten the health of
More informationEui Hyun Kim. Department of Medicine The Graduate School, Yonsei University
Immediate postoperative growth hormone level and early postoperative oral glucose tolerance test as predictive tools for the long-term surgical remission in acromegaly Eui Hyun Kim Department of Medicine
More informationImpact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined Approach
Radiosurgery as part of the neurosurgical armamentarium: Educational Symposium November 24 th 2011 Impact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined
More informationLong term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas
Pituitary (2010) 13:223 229 DOI 10.1007/s11102-010-0221-z Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas Edward F. Chang Michael E. Sughrue
More informationTREATMENT OF CUSHING S DISEASE
TREATMENT OF CUSHING S DISEASE Surgery, Radiation, Medication Peter J Snyder, MD Professor of Medicine Disclosures Novartis Research grant Pfizer Consultant Ipsen Research grant Cortendo Research grant
More informationImaging The Turkish Saddle. Russell Goodman, HMS III Dr. Gillian Lieberman
Imaging The Turkish Saddle Russell Goodman, HMS III Dr. Gillian Lieberman Learning Objectives Review the anatomy of the sellar region Discuss the differential diagnosis of sellar masses Discuss typical
More informationResearch Paper: Management of Pituitary Adenomas: Mononostril Endoscopic Transsphenoidal Surgery
Basic and Clinical March, April 2018, Volume 9, Number 2 Research Paper: Management of Pituitary Adenomas: Mononostril Endoscopic Transsphenoidal Surgery Houssein Darwish 1,2, Usamah El-Hadi 3, Georges
More informationEndoscopic Endonasal Surgery for Subdiaphragmatic Type Craniopharyngiomas
Original Article doi: 10.2176/nmc.oa.2018-0028 Neurol Med Chir (Tokyo) 58, 260 265, 2018 Endoscopic Endonasal Surgery for Subdiaphragmatic Type Craniopharyngiomas Hiroshi NISHIOKA, 1,2 Yuichi NAGATA, 1
More informationSee the latest estimates for new cases of pituitary tumors in the US and what research is currently being done.
About Pituitary Tumors Overview and Types If you have been diagnosed with a pituitary tumor or worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What
More informationCase Report Successful Pregnancy in a Female with a Large Prolactinoma after Pituitary Tumor Apoplexy
Case Reports in Obstetrics and Gynecology Volume 2013, Article ID 817603, 4 pages http://dx.doi.org/10.1155/2013/817603 Case Report Successful Pregnancy in a Female with a Large Prolactinoma after Pituitary
More informationPituitary Tumors: adenoma, craniopharyngioma, rathke cyst
Pituitary Tumors: adenoma, craniopharyngioma, rathke cyst Overview Tumors that grow from the pituitary gland can affect the whole body by interfering with normal hormone levels. They can also cause headaches
More informationHigh and Low GH: an update of diagnosis and management of GH disorders
High and Low GH: an update of diagnosis and management of GH disorders Georgia Chapter-AACE 2017 Laurence Katznelson, MD Professor of Medicine and Neurosurgery Associate Dean of Graduate Medical Education
More informationPituitary adenoma is one of the common brain. Pituitary Adenoma Surgery: Retrospective Analysis of My Personal Experience
Original Article Nepal Journal of Neuroscience 13:63-67, 2016 Prabin Shrestha, MD, PhD Anish M Singh, MS Address for correspondence: Prabin Shrestha, MD, PhD Email: prabinshrestha@hotmail.com Received,
More informationPituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group
Pituitary Tumors and Incidentalomas Bijan Ahrari, MD, FACE, ECNU Palm Medical Group Background Pituitary incidentaloma: a previously unsuspected pituitary lesion that is discovered on an imaging study
More informationThe subjects were participants in a Dutch national prospective study, running from April
Supplemental Data Subjects The subjects were participants in a Dutch national prospective study, running from April 1, 1994 to April 1, 1996. Infants with neonatal screening results indicative of CH-C
More informationCase Report Rapid Pituitary Apoplexy Regression: What Is the Time Course of Clot Resolution?
Case Reports in Radiology Volume 2015, Article ID 268974, 5 pages http://dx.doi.org/10.1155/2015/268974 Case Report Rapid Pituitary Apoplexy Regression: What Is the Time Course of Clot Resolution? Devon
More informationW. CHRISTOPHER FOX, M.D., 1 SCOTT WAWRZYNIAK, 2 AND WILLIAM F. CHANDLER, M.D. 1. be very useful during transsphenoidal pituitary surgery as well.
J Neurosurg 108:746 750, 2008 Intraoperative acquisition of three-dimensional imaging for frameless stereotactic guidance during transsphenoidal pituitary surgery using the Arcadis Orbic System W. CHRISTOPHER
More informationIn some patients with pituitary macroadenoma, visual acuity
ORIGINAL RESEARCH A.M. Tokumaru I. Sakata H. Terada S. Kosuda H. Nawashiro M. Yoshii Optic Nerve Hyperintensity on T2-Weighted Images among Patients with Pituitary Macroadenoma: Correlation with Visual
More informationEndoscopic Endonasal Transsphenoidal Approach for Pituitary Adenomas: a Prospective Review of Our Early Experience
Endoscopic Endonasal Transsphenoidal Approach for Pituitary Adenomas: a Prospective Review of Our Early Experience Rostam Poormousa 1, Kaveh Haddadi 2*, Misagh Shafizad 3, Sajjad Shafiee 3 1 MD, Assistant
More informationStudies on the diagnosis and treatment of canine Cushing s disease
Studies on the diagnosis and treatment of canine Cushing s disease Summary of the Doctoral Thesis Asaka Sato (Supervised by Professor Yasushi Hara) Graduate School of Veterinary Medicine and Life Science
More informationHHS Public Access Author manuscript Neurosurg Focus. Author manuscript; available in PMC 2016 August 22.
The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite Hasan A.
More informationCYSTIC PROLACTINOMA: A SURGICAL DISEASE?
AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,
More informationProcess / Evidence Class. Clinical Assessment / III
Table 2: Endocrine Author Cozzi et al (2009) 1 Study Design: Prospectively followed case series. Fourteen patients had pre-op hypocortisolism. Patient Population: Seventy-two adult patients who underwent
More informationTABLES. Imaging Modalities Evidence Tables Table 1 Computed Tomography (CT) Imaging. Conclusions. Author (Year) Classification Process/Evid ence Class
TABLES Imaging Modalities Evidence Tables Table 1 Computed Tomography (CT) Imaging Author Clark (1986) 9 Reformatted sagittal images in the differential diagnosis meningiomas and adenomas with suprasellar
More informationDelayed Hyponatremia Following Transsphenoidal Surgery for Pituitary Adenoma
Neurol Med Chir (Tokyo) 48, 489 494, 2008 Delayed Hyponatremia Following Transsphenoidal Surgery for Pituitary Adenoma Jae Il LEE, WonHoCHO*, ByungKwanCHOI, Seung Heon CHA, Geun Sung SONG, and Chang Hwa
More informationJMSCR Vol 05 Issue 01 Page January 2017
MEN1, AIP, PRKAR1A and CDKN1B are familial pituitary syndromes found to be associated with four different genes. Pituitary gland is situated in hypophyseal fossa which is bounded supero-laterally by dural
More informationSurgical Neurology International
Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of California, Los Angeles, CA, USA Original
More informationBroersen et al. Orphanet Journal of Rare Diseases (2019) 14:64 (Continued on next page)
Broersen et al. Orphanet Journal of Rare Diseases (2019) 14:64 https://doi.org/10.1186/s13023-019-1038-0 RESEARCH Open Access Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort
More informationRadioterapia degli adenomi ipofisari
Radioterapia degli adenomi ipofisari G Minniti Radiation Oncology, Sant Andrea Hospital, University of Rome Sapienza, and IRCCS Neuromed, Pozzilli (IS) Roma 6-9 Novembre 14 ! Outline " Radiation techniques
More informationSkullbase Lesions. Skullbase Surgery Open vs endoscopic. Choice Of Surgical Approaches 12/28/2015. Skullbase Surgery: Evolution
Skullbase Lesions Skullbase Surgery Open vs endoscopic Prof Asim Mahmood,FRCS,FACS,FICS,FAANS, Professor of Neurosurgery Henry Ford Hospital Detroit, MI, USA Anterior Cranial Fossa Subfrontal meningioma
More informationGamma knife surgery in management of secretory pituitary adenoma Preliminary evaluation of role, efficacy and safety
International Journal of Clinical Medicine Research 2014; 1(2): 48-56 Published online June 10, 2014 (http://www.aascit.org/journal/ijcmr) Gamma knife surgery in management of secretory pituitary adenoma
More informationPeri-op Pituitary / Diabetes Insipidus/ Apoplexy Dr. Stan Van Uum, MD, PhD, FRCPC
10 th Annual Canadian Endocrine Update 3 rd Canadian Endocrine Review Course Peri-op Pituitary / Diabetes Insipidus/ Apoplexy Dr. Stan Van Uum, MD, PhD, FRCPC 10 th Annual Canadian Endocrine Update Dr.
More informationPreoperative Short-term Administration of Octreotide for Facilitating Transsphenoidal Removal of Invasive
Preoperative Short-term Administration of Octreotide for Facilitating Transsphenoidal Removal of Invasive Growth Hormone-secreting Macroadenomas Eiji TACHIBANA, Kiyoshi SAITO, and Jun YOSHIDA, Nagoya University
More informationCriteria for early CLINICAL STUDY. N Fujimoto 1, N Saeki 2, O Miyauchi 1
(2002) 16, 731 738 2002 Nature Publishing Group All rights reserved 0950-222X/02 $25.00 www.nature.com/eye N Fujimoto 1, N Saeki 2, O Miyauchi 1 Criteria for early and E Adachi-Usami 1 detection of temporal
More informationLaurie A. Loevner, MD
Laurie A. Loevner, MD Chief, Division of Neuroradiology UPHS Professor of Radiology, Otorhinolaryngology: Head & Neck Surgery, Neurosurgery, and Ophthalmology University of Pennsylvania Health System Disclosures
More informationMR of the Pituitary Gland Postsurgery: Serial MR Studies following Transsphenoidal Resection
MR of the Pituitary Gland Postsurgery: Serial MR Studies following Transsphenoidal Resection Thomas S. Dina, 1 5 Samuel H. Feaster, 1.3 Edward R. Laws, Jr., 2 4 and David 0. Davis 1 PURPOSE: To determine
More informationProlactin response to an acute bromocriptine suppression test (ABST) following surgical debulking of macroprolactinomas
Original Investigation Prolactin response to an acute bromocriptine suppression test (ABST) following surgical debulking of macroprolactinomas Lora Stanka Kirigin 1, Mateja Strinović 1, Gorana Mirošević
More informationEfficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
J Korean Med Sci 2009; 24: 874-8 ISSN 1011-8934 DOI: 10.3346/jkms.2009.24.5.874 Copyright The Korean Academy of Medical Sciences Efficacy and Safety of Cabergoline as First Line for Invasive Giant Prolactinoma
More informationCertain types of tumors, in the CNS and elsewhere,
clinical article J Neurosurg 122:798 802, 2015 Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly Lucia Schwyzer, MD, Robert M. Starke, MD, John
More informationManaging Acromegaly: Review of Two Cases
Managing Acromegaly: Review of Two Cases INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of patients with acromegaly who have
More informationPITUITARY: JUST THE BASICS PART 2 THE PATIENT
PITUITARY: JUST THE BASICS PART 2 THE PATIENT DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and
More informationOriginal Article. Abstract. Introduction. Thinesh Kumran 1,2, Saffari Haspani 1,2, Jafri Malin Abdullah 1,4, Azmi Alias 1,2, Fan Rui Ven 3
Original Article Factors Influencing Disconnection Hyperprolactinemia and Reversal of Serum Prolactin after Pituitary Surgery in a Non-Functioning Pituitary Macroadenoma Thinesh Kumran 1,2, Saffari Haspani
More informationCSF Rhinorrhoea after Transsphenoidal Surgery
ISPUB.COM The Internet Journal of Neurosurgery Volume 5 Number 1 CSF Rhinorrhoea after Transsphenoidal Surgery E Elgamal Citation E Elgamal. CSF Rhinorrhoea after Transsphenoidal Surgery. The Internet
More informationSilent ACTHoma: A subclinical presentation of Cushing s disease in a 79 year old male
575 Silent ACTHoma: A subclinical presentation of Cushing s disease in a 79 year old male Meenal Malviya 1, Navneet Kumar 1*, Naseer Ahmad 2 1 MD; Department of Internal Medicine, Providence Hospital &
More information182 Ligia Tataranu et al Endoscopic endonasal transsphenoidal approach
182 Ligia Tataranu et al Endoscopic endonasal transsphenoidal approach Endoscopic endonasal transsphenoidal approach in the management of sellar and parasellar lesions: alternative surgical techniques,
More informationPitfalls in early biochemical evaluation after transsphenoidal
2017, 64 (1), 1-10 Original Advance Publication doi: 10.1507/endocrj.EJ17-0261 Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly Hiroshi Nishioka 1), 3),
More informationApplication of neuronavigation in Neurosurgery at King Hussein Medical Center, Jordan
Keeping up with technology Application of neuronavigation in Neurosurgery at King Hussein Medical Center, Jordan Abdullah al-akayleh Department of Neuosurgery, King Hussean Medical Center, Jordan. ABSTRACT
More informationAcromegaly: Management of the Patient Who Has Failed Surgery
Acromegaly: Management of the Patient Who Has Failed Surgery Minnesota/Midwest Chapter of the American Association of Clinical Endocrinologists 8 th Annual Meeting October 14, 2017 Mark E. Molitch, M.D.
More informationHyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea
Clin Pediatr Endocrinol 1996; 5(2), 61-66 Copyright (C) 1996 by The Japanese Society for Pediatric Endocrinology Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea Toshihisa Okada, Soroku
More informationError analysis in neuronavigation
Fakultät für Informatik - Humanoids and Intelligence Systems Lab Institut für Anthropomatik Mittwochs von 12:15-13:45 Error analysis in neuronavigation Uwe Spetzger Neurochirurgische Klinik, Klinikum Karlsruhe
More informationcc/kg mmol/kg ADH i- Incidental ii- Hour glass iii- Diabetes Insipidus iv- Centeral diabetes insipidus v -Supra optic vi- Median emminance iii
( ) - ()... (DI) : DI. :. DI ( ) DI.... - DI. ( ) ( ) Immediate DI DI. Minirin DI DI DI (%) :. ( ) Delayed DI ( ) (%/) DI. Delayed DI (%) Immediate DI (%) DI.. (%/) (%/) (%/) Delayed DI. DI Minirin (%)
More informationRADIOANATOMY OF SELLA TURCICA
RADIOANATOMY OF SELLA TURCICA O.BAKKACHA, H.MALAJATI, M.RHISSASSI, H. BENCHAABOUNE, N.CHAKIR, My R. EL HASSANI,M.JIDDANE Department of Neuroradiology specialties Hospital. Rabat Objective: New imaging
More informationMagnetic Resonance Imaging Criteria to Predict Complete Excision of Parasellar Pituitary Macroadenoma on Postoperative Imaging
Original Article 41 Magnetic Resonance Imaging Criteria to Predict Complete Excision of Parasellar Pituitary Macroadenoma on Postoperative Imaging S. E. J. Connor 1 F. Wilson 2 K. Hogarth 3 1 Department
More information10/23/2010. Excludes Single Surgeon Pituitary (N=~140) Skull Base Volume 12 Month UC SF. Patients. Anterior/Midline. Pituitary CSF Leak.
Advances in Pituitary Surgery Ivan El-Sayed MD, FACS Director- Otolaryngology Minimally Invasive Skull Base Surgery Program Otolaryngology-Head and Neck Surgery University of California-San Francisco Minimally
More informationManaging Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide)
Managing Acromegaly: Biochemical Control with SIGNIFOR LAR (pasireotide) INDICATION AND USAGE SIGNIFOR LAR (pasireotide) for injectable suspension is a somatostatin analog indicated for the treatment of
More informationUrgent and Emergent Pituitary Conditions
Urgent and Emergent Pituitary Conditions PANKAJ A. GORE, MD DIRECTOR, BRAIN AND SKULL BASE T UMOR SURGERY PROVIDENCE B R AIN AND S PINE I NSTITUTE Urgent and Emergent Pituitary Conditions Neurosurgical
More informationInt J Clin Exp Med 2015;8(11): /ISSN: /IJCEM
Int J Clin Exp Med 2015;8(11):21557-21564 www.ijcem.com /ISSN:1940-5901/IJCEM0018374 Original Article Effect of transsphenoidal surgery and standard care on fertility related indicators of patients with
More informationCase Report GH-Producing Pituitary Adenoma and Concomitant Rathke s Cleft Cyst: A Case Report and Short Review
Case Reports in Neurological Medicine Volume 2015, Article ID 948025, 6 pages http://dx.doi.org/10.1155/2015/948025 Case Report GH-Producing Pituitary Adenoma and Concomitant Rathke s Cleft Cyst: A Case
More informationHypothalamus & Pituitary Gland
Hypothalamus & Pituitary Gland Hypothalamus and Pituitary Gland The hypothalamus and pituitary gland form a unit that exerts control over the function of several endocrine glands (thyroid, adrenals, and
More informationMedStar Pituitary Center. Expert, Experienced Care for Pituitary Disorders
MedStar Pituitary Center Expert, Experienced Care for Pituitary Disorders Pictured clockwise from the back left are Kenneth Burman, MD, Endocrinology; Edward Aulisi, MD, Neurosurgery; Stanley Chia, MD,
More informationCase Report. Michael H. Goldman, MD; Alison T. Gruber; Marc A. Herman, MD ABSTRACT
Case Report CONCURRENT PANHYPOPITUITARISM AND HYPERPROLACTINEMIA DUE TO A GIANT INTERNAL CAROTID ANEURYSM REVEALED BY THYROID HORMONE WITHDRAWAL DURING FOLLOW-UP MANAGEMENT OF THYROID CANCER Michael H.
More informationManagement of incidental pituitary microadenomas: a cost-effectiveness analysis King J T, Justice A C, Aron D C
Management of incidental pituitary microadenomas: a cost-effectiveness analysis King J T, Justice A C, Aron D C Record Status This is a critical abstract of an economic evaluation that meets the criteria
More informationClinical Study Retrospective Analysis of Cushing s Disease with or without Hyperprolactinemia
International Endocrinology, Article ID 919704, 8 pages http://dx.doi.org/10.1155/2014/919704 Clinical Study Retrospective Analysis of Cushing s Disease with or without Hyperprolactinemia Cheng Huan, 1
More informationCase Report Endoscopic Endonasal Transsphenoidal Resection for Pituitary Apoplexy during the Third Trimester of Pregnancy
Surgery Research and Practice, Article ID 397131, 4 pages http://dx.doi.org/10.1155/2014/397131 Case Report Endoscopic Endonasal Transsphenoidal Resection for Pituitary Apoplexy during the Third Trimester
More informationMANAGEMENT OF HYPERGLYCEMIA IN A PATIENT WITH ACROMEGALY TREATED WITH PASIREOTIDE LAR: A CASE STUDY
Case Report MANAGEMENT OF HYPERGLYCEMIA IN A PATIENT WITH ACROMEGALY TREATED WITH PASIREOTIDE LAR: A CASE STUDY Murray B. Gordon, MD, FACE; Kellie L. Spiller, MS ABSTRACT Submitted for publication July
More informationWebinar. ENDOSCOPIC PITUITARY SURGERY A multidisciplinary approach beyond the traditional pathways. September 11, :00 17:00
Webinar ENDOSCOPIC PITUITARY SURGERY A multidisciplinary approach beyond the traditional pathways September 11, 2015 14:00 17:00 Date : 11/9/2015 Title ENDOSCOPIC PITUITARY SURGERY: a multidisciplinary
More information(3) Pituitary tumours
Hypopituitarism Diabetes Insipidus Pituitary tumours (2) Dr T Kemp - Endocrinology and Metabolism Unit - Steve Biko Academic Hospital (3) Pituitary tumours Pituitary microadenoma - intrasellar adenoma
More informationThe Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord
The Low Sensitivity of Fluid-Attenuated Inversion-Recovery MR in the Detection of Multiple Sclerosis of the Spinal Cord Mark D. Keiper, Robert I. Grossman, John C. Brunson, and Mitchell D. Schnall PURPOSE:
More informationThe efficacy and morbidity for transsphenoidal surgery. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations
J Neurosurg 121:67 74, 2014 AANS, 2014 Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations Clinical article Arman Jahangiri, B.S., Jeffrey Wagner, B.S., Sung Won Han, Corinna
More informationRadiotherapy approaches to pituitary tumors
Disclosures No relevant disclosures Radiotherapy approaches to pituitary tumors Pituitary Disorders: Advances in Diagnosis and Management Steve Braunstein, MD, PhD UCSF Department of Radiation Oncology
More informationACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST
Case Report ACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST Anupa Sharma, DO 1 ; Eric K.Richfield, MD, PhD 2 ; Sara E. Lubitz, MD 1 ABSTRACT
More informationPITUITARY ADENOMAS. Effective Date: August, 2012
CLINICAL PRACTICE GUIDELINE CNS-00 PITUITARY ADENOMAS Effective Date: August, 2012 The recommendations contained in this guideline are a consensus of the Alberta Provincial CNS Tumour Team synthesis of
More informationSven Berkmann, M.D., 1 Sven Schlaffer, M.D., 1 Christopher Nimsky, M.D., Ph.D., 1,2 1
J Neurosurg 121:1166 1175, 2014 AANS, 2014 Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma Clinical article Sven Berkmann, M.D., 1 Sven Schlaffer, M.D.,
More informationPrevalence of Meniscal Radial Tears of the Knee Revealed by MRI After Surgery
Downloaded from www.ajronline.org by 46.3.207.114 on 12/22/17 from IP address 46.3.207.114. Copyright RRS. For personal use only; all rights reserved Thomas Magee 1 Marc Shapiro David Williams Received
More informationRole of the superior turbinate when performing endoscopic endonasal transsphenoidal approach
O R I G I N A L A R T I C L E Folia Morphol. Vol. 73, No. 1, pp. 73 78 DOI: 10.5603/FM.2014.0010 Copyright 2014 Via Medica ISSN 0015 5659 www.fm.viamedica.pl Role of the superior turbinate when performing
More informationGLMS CME- Cell Group 5 10 April Greenlane Medical Specialists Pui-Ling Chan Endocrinologist
GLMS CME- Cell Group 5 10 April 2018 Greenlane Medical Specialists Pui-Ling Chan Endocrinologist Pituitary case one Mrs Z; 64F Seen ORL for tinnitus wax impaction MRI Head Pituitary microadenoma (3mm)
More informationSurgical Orthodontic Correction of Acromegaly with Mandibular Prognathism
Case Report Surgical Orthodontic Correction of Acromegaly with Mandibular Prognathism Takakaza Yagi, DDS, PhD a ; Masayoshi Kawakami, DDS, PhD b ; Kenji Takada, PhD, DDS c Abstract: A male (30 years five
More informationM. PIEMONTE SOC O.R.L. Az. Ospedaliero-Universitaria S.M.M., Udine
M. PIEMONTE SOC O.R.L. Az. Ospedaliero-Universitaria S.M.M., Udine LIMITS OF ENDOSCOPIC RESECTIONS IN ANTERIOR SKULL BASE TUMORS Limiti delle resezioni endoscopiche nei tumori della rinobase anteriore
More informationEndoscopic Pituitary Surgery (transsphenoidal)
Endoscopic Pituitary Surgery (transsphenoidal) Overview Endoscopic surgery is performed through the nose to remove tumors from the pituitary gland and skull base. In this minimally invasive surgery, the
More informationPituitary apoplexy 台北榮總內分泌新陳代謝科主治醫師林怡君
Pituitary apoplexy 台北榮總內分泌新陳代謝科主治醫師林怡君 Williams text book of endocrinology 11 th e Anterior pituitary hormone 10-20% of pituitary cells, increase to 40% during AP PRL releasing factors: TRH, oxytocin,
More information